FeesSafety
Pluang+

Coda Octopus beats Q3 earnings and revenue estimates with strong defense and acoustic sales.

Company Fundamentals
14 Sep 2026
Andrew Wynn
View Source
Bullish
Coda Octopus beats Q3 earnings and revenue estimates with strong defense and acoustic sales.

Coda Octopus Group reported Q3 earnings per share of $0.12 and revenue of $7.7 million, exceeding analyst expectations. The company's growth was driven by its defense engineering and acoustic businesses, which offset a decline in marine technology sales affected by geopolitical instability. Pretax income rose 16% to $1.8 million, highlighting strong financial health with a current ratio of 33.02 and a P/E ratio of 24.18. These results suggest resilience despite challenges in some market segments.

Coda Octopus Group's Q3 earnings and revenue results provide context for readers. For those tracking the Technology sector, 79 of 150 US stocks on Pluang rose while 69 fell. Notable movers include COIN at USD 192.34 (+9.75%), APPN at USD 38.04 (+9.44%), and IT at USD 196.13 (+9.21%) as of Sep 15, 2026 02:32 WIB.

More News

Chery debuts Super Intelligent Valet Parking to ease family parking hassles and save time.

Chery debuts Super Intelligent Valet Parking to ease family parking hassles and save time.

At the 2026 Chery International User Summit, Chery introduced its Super Intelligent Valet Parking (SIVP) system, designed to simplify parking for families. The system uses advanced sensors and AI to enable features like One Tap Departure and One Step...

Others
Bullish
2 hours ago
US margin debt rises 1.8% in September, hitting $1.48 trillion, up 31.4% year-over-year.

US margin debt rises 1.8% in September, hitting $1.48 trillion, up 31.4% year-over-year.

Margin debt in the US increased by 1.8% in September, reaching $1.48 trillion. This represents a 31.4% increase compared to the same month last year, or 26.7% when adjusted for inflation. The rise in margin debt indicates growing investor borrowing, ...

Market News
Neutral
4 hours ago
Zomedica highlights clinical evidence behind its veterinary products in investor webinar

Zomedica highlights clinical evidence behind its veterinary products in investor webinar

Zomedica held an investor webinar focusing on its clinical programs and evidence-based adoption of veterinary products. The company emphasized that veterinarians prefer products supported by published data, which Zomedica integrates into its three ma...

Market News
Bullish
4 hours ago
One biotech IPO launched, four filed, and one IPO is set for next week amid investor anticipation.

One biotech IPO launched, four filed, and one IPO is set for next week amid investor anticipation.

This week saw the debut of one biotech IPO, Lycia Therapeutics, which priced its upsized offering at the top of the range. Additionally, four companies filed initial IPO documents, including two significant biotech firms. Investors are closely watchi...

Others
Bullish
4 hours ago
Cysic to burn 7.2M tokens to counter unauthorized minting on BNB Chain

Cysic to burn 7.2M tokens to counter unauthorized minting on BNB Chain

Cysic plans to burn 7.2 million of its tokens from the foundation reserve to counteract unauthorized creation of 10 million CYS tokens on the BNB Chain during a security breach on October 17. The breach involved the Cysic bridge, which transfers toke...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App